首頁
Malaghan Institute of Medical Research

11月 2025Malaghan Institute of Me...的市場佔有率分析

The Malaghan Institute of Medical Research is an independent biomedical research institute based in Wellington, New Zealand. The Malaghan Institute specialises in the immune system, and how it can be harnessed to improve human health.

健康 > 醫學

域名malaghan.org.nz

成立年份1966

僱員51 - 200

年度營收--

Malaghan Institute of Medical Research

Malaghan Institute of Medical Research（包含公司地區）

malaghan.org.nz

查看更多網站流量與參與度資訊

Malaghan Institute of Medical Research的熱門網域總造訪量

了解Malaghan Institute of Medical Research市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

malaghan.org.nz10.8K

透過銷售情報查看更多內容

Malaghan Institute of Medical Research的熱門網域平均造訪時長

分析Malaghan Institute of Medical Research參與度指標。

過去 3 個月平均造訪時長

子公司細目

malaghan.org.nz00:00:55

透過銷售情報查看更多內容

Malaghan Institute of Medical Research的熱門網域平均頁面瀏覽量

了解Malaghan Institute of Medical Research如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

malaghan.org.nz1.89

透過銷售情報查看更多內容

Malaghan Institute of Medical Research按網域劃分的熱門競爭對手

11月 2025的熱門類似網站，依相似度排名

wirb.com公司名Western Institutional Review Board, Inc.僱員201 - 500總部美國, 華盛頓, Olympia年度營收$50M - $75M訪問總量--健康 > 醫學

使用的熱門技術Malaghan Institute of Medical Research

这些是Malaghan Institute of Medical Research顶级域名使用的行业网站技术

社群 (7)

Instagram

付費廣告 (5)

DoubleClick

付款與貨幣 (5)

PayPal

音訊視訊媒體 (3)

YouTube

更多技術

11

檢視所有

新聞與訊號來自Malaghan Institute of Medical Research

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Malaghan Institute and Wellington Zhaotai Therapies Limited attended event KiwiNet research commercialisation awards on Jan 1st '25.The Malaghan Institute's CAR T-cell programme features twice in this year's KiwiNet research commercialisation awards, New Zealand's premiere celebration of research commercialisation.

新聞Malaghan Institute and Wellington Zhaotai Therapies Limited hires Delahunt.Retired RFL board member and world-renowned researcher brett Delahunt joins the Malaghan Institute.

新聞Bioora partners with Malaghan Institute and Wellington Zhaotai Therapies Limited.BioOra said its lead product was a novel third-generation CAR-T therapy, developed in collaboration with the Malaghan Institute of Medical Research in Wellington, that was in a Phase II clinical trial in New Zealand.